Gene therapy using the human telomerase catalytic subunit gene promoter enables targeting of the therapeutic effects of vesicular stomatitis virus matrix protein against human lung adenocarcinoma

Author:                      

Publisher: Spandidos Publications

ISSN: 1792-0981

Source: Experimental and Therapeutic Medicine, Vol.4, Iss.5, 2012-01, pp. : 859-864

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract